PEG-3350 with Electolytes and Ranibizumab Intraocular
Determining the interaction of PEG-3350 with Electolytes and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte, Suclear
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- PEG-3350 with Electolytes-Ranibizumab ophthalmic
- PEG-3350 with Electolytes-Ranitidine
- PEG-3350 with Electolytes-Ranitidine Capsule
- PEG-3350 with Electolytes-Ranitidine Hydrochloride
- PEG-3350 with Electolytes-Ranitidine Injection
- PEG-3350 with Electolytes-Ranitidine Suspension
- Ranibizumab Intraocular-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Ranibizumab Intraocular-PEG-Prep and Bisacodyl
- Ranibizumab Intraocular-PEG3350
- Ranibizumab Intraocular-Pegademase bovine
- Ranibizumab Intraocular-Pegademase Bovine Injection
- Ranibizumab Intraocular-Pegademase bovine Intramuscular